Biomarker for prostate cancer
AssigneeNational Taiwan University
InventorsYeong-Shiau PU, Chung-Hsin CHEN, Pei-Wen HSIAO, Ming-Shyue LEE, Hsiang-Po HUANG, Kai-Hsiung CHANG
Life of this patent
Estimating the term…
Abstract
Provided is a method of accurate and sensitive characterization and prognosis of prostate cancer in a subject. The method includes obtaining a biological sample from the subject and determining the level of identified biomarkers.
Claims13
A method to characterize prostate cancer in a subject in need thereof, comprising detecting a level of a prostate cancer marker in a biological sample from the subject, wherein the prostate cancer marker comprises one or more of metabolite markers in Tables 1, 2, 5 and 6.
A method for determining a need of biopsy for prostate cancer diagnosis in a subject in need thereof, comprising detecting a level of a prostate cancer marker in a biological sample from the subject, wherein the prostate cancer marker is selected from the group consisting of panels in Tables 3, 4, 7 and 8.
A method for monitoring a prostate cancer subject on active surveillance (AS), comprising detecting a level of a prostate cancer marker in a biological sample from the subject, wherein the prostate cancer marker is selected from the group consisting of markers in Tables 1, 2, 5 and 6.
Dependencies are inferred from the claim text.